Seung T. Lee

Seung T. Lee

Hematology Oncology | Oncology

22 South Greene Street
Floor 1
Baltimore, MD 21201

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

Journal: European journal of haematology

Published: October 20, 2025

Unexpected Diagnosis of Non-Hodgkin Lymphoma After Liver Transplant: A Case Report of Suspected Neuroendocrine Tumor Recurrence Managed with Robotic Distal Pancreatectomy and Splenectomy.

Unexpected Diagnosis of Non-Hodgkin Lymphoma After Liver Transplant: A Case Report of Suspected Neuroendocrine Tumor Recurrence Managed with Robotic Distal Pancreatectomy and Splenectomy.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Published: September 10, 2025

Comprehensive Assessment of CD19 Immunohistochemical Staining in Classic Hodgkin Lymphoma.

Comprehensive Assessment of CD19 Immunohistochemical Staining in Classic Hodgkin Lymphoma.

Journal: The American journal of surgical pathology

Published: June 28, 2025

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.

Journal: Blood advances

Published: May 13, 2025

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.

Journal: Blood

Published: February 18, 2025

CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant.

CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 15, 2024

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.

Journal: The New England journal of medicine

Published: June 20, 2024

Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis.

Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: February 08, 2024

Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease.

Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease.

Journal: Leukemia research

Published: August 29, 2023

Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by 18F-FDG PET/CT Imaging Following CAR-T Therapy.

Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by 18F-FDG PET/CT Imaging Following CAR-T Therapy.

Journal: Clinical lymphoma, myeloma & leukemia

Published: February 05, 2023

Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma.

Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma.

Journal: Cancer investigation

Published: January 19, 2023

A Case of Acute Myeloid Leukemia-Associated Necrotizing Sweet Syndrome.

A Case of Acute Myeloid Leukemia-Associated Necrotizing Sweet Syndrome.

Journal: Case reports in dermatology

Published: September 02, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026